Tuesday, March 31, 2015

PharmGKB and Stanford Law School student collaboration

›
The Stanford Law School blog recently highlighted the collaboration between Stanford law students and PharmGKB to write a response to the FD...
Friday, March 27, 2015

NAT2 plays a role in insulin sensitivity

›
N-acetyltransferase 2 (NAT2) has long been known to metabolize xenobiotics but the endogenous substrates of NAT2 remain unknown. A new s...
Thursday, March 26, 2015

New CPIC Guideline: CYP3A5 and Tacrolimus

›
Guidelines regarding the use of pharmacogenetic tests for CYP3A5 in dosing tacrolimus have been published in Clinical Pharmacology and Ther...
Thursday, March 5, 2015

ABCB5 and haloperidol-induced toxicity: Results from a new study

›
Approximately 50% of patients treated with the antipsychotic drug haloperidol will develop extrapyramidal symptoms, a category that includes...
Wednesday, February 25, 2015

Our 10-step guide to enabling your PGx study to be curated

›
At PharmGKB we manually curate pharmacogenetic (PGx) associations found in published articles and add them to our database. However, lack of...
Wednesday, February 18, 2015

PharmGKB VIP summary for CFTR published

›
The PharmGKB summary describing CFTR as a pharmacogene has been published by Pharmacogenetics & Genomics. Genetic variants within the CF...
Sunday, February 8, 2015

FDA Proposed Regulation of Laboratory Developed Tests (LDTs)

›
Dear Colleagues, As you may know, the FDA is considering regulating laboratory developed tests (LDTs) and had an open comment period that ...